Dana
ExamplePersonal list
Starting a GLP-1, thoughtfully
Everything I want to talk through with a clinician before starting a GLP-1, plus the basics I keep reading I should not skip.
SemaglutideTirzepatidePsylliumCreatine monohydrateVitamin D
No. 002medication
Tirzepatide
Tirzepatide is a medication that is FDA-approved, prescription only.
Also known as Zepbound, Mounjaro, GIP/GLP-1
Tirzepatide acts on two gut hormone receptors, GIP and GLP-1, to reduce appetite and improve blood sugar control. It is sold as Zepbound for chronic weight management and obstructive sleep apnea with obesity, and as Mounjaro for type 2 diabetes.
In 1 example journal
Is Tirzepatide FDA-approved?
Approved by the FDA. A licensed clinician has to decide it is right for you and prescribe it. FDA-approved, prescription only. Tirzepatide left FDA's shortage list in December 2024, and in April 2026 FDA proposed excluding it from the 503B outsourcing bulks list; compounded versions are no longer an FDA-sanctioned substitute when the approved drug is available.
As of September 23, 2026.
Key takeaways
- Tirzepatide acts on two appetite hormones, GIP and GLP-1. It is sold as Zepbound for weight and sleep apnea, and as Mounjaro for type 2 diabetes.
- In the SURMOUNT-1 trial, participants lost about 15% to 21% of their body weight on average over 72 weeks, depending on dose group, versus about 3% on placebo.
- In 2024 it became the first medication FDA approved for obstructive sleep apnea in adults with obesity.
- Stopping usually means regaining weight: in SURMOUNT-4, people switched to placebo regained a large share of what they had lost.
How does Tirzepatide work?
Tirzepatide is one molecule that switches on two gut-hormone receptors, GIP and GLP-1. Both are found in the parts of the brain that manage appetite, so you tend to feel full sooner and eat less.
In type 2 diabetes it also helps the pancreas release insulin and lowers glucagon, but only when blood sugar is high. That is why the same drug is sold under two names for two uses.
What does the evidence say about Tirzepatide?
Strong human evidenceLarge randomized trials (the SURMOUNT program) show substantial average weight loss compared with placebo.
What to expect
What trials and prescribing information measured over time. Everyone responds differently.
- First months
Treatment starts low and increases gradually. The label notes that nausea, vomiting and diarrhea mostly happened while the dose was being increased and decreased over time.
- Week 72
In SURMOUNT-1, most participants had reached a weight plateau by week 72, having lost about 15% to 21% of body weight on average depending on dose group, versus about 3% on placebo.
- Week 52 (sleep apnea)
In SURMOUNT-OSA, breathing interruptions during sleep had fallen by roughly 25 to 29 events an hour on average at week 52, versus about 5 with placebo.
- If you stop
In SURMOUNT-4, people who stayed on tirzepatide kept losing weight, while those switched to placebo regained about 14% of their body weight over the following year.
What do clinicians say about Tirzepatide?
Guidelines treat tirzepatide as one of the most effective obesity medications available, best used long term and alongside nutrition and activity. They advise against compounded copies.
The ADA 2026 Standards of Care prefer GLP-1 or dual GIP/GLP-1 drugs for people with obesity and type 2 diabetes, heart disease, a type of heart failure, fatty liver disease or knee osteoarthritis.
ADA Standards of Care 2026, Section 8: Obesity and weight management (Guideline Central summary)AACE's 2025 obesity algorithm treats obesity as a chronic disease that needs long-term treatment, organized around the complications a person has.
AACE consensus statement: algorithm for the evaluation and treatment of adults with obesity (2025)FDA approved Zepbound in December 2024 as the first medication for moderate to severe obstructive sleep apnea in adults with obesity, based on two 52-week studies.
FDA (Dec 2024): FDA approves first medication for obstructive sleep apneaFDA has received more than 730 adverse event reports for compounded tirzepatide, and the Obesity Medicine Association and partner groups advise patients not to use compounded versions.
FDA: Concerns with unapproved GLP-1 drugs used for weight lossIn April 2026 FDA proposed excluding tirzepatide from the list of bulk ingredients outsourcing facilities may compound from, citing no clinical need.
FDA (Apr 30, 2026): Proposal to exclude semaglutide, tirzepatide and liraglutide from the 503B bulks list
Summaries of published guidelines, drug labels, regulators and reviews, each attributed to its source. DiscoverMedica does not employ clinicians.
Is Tirzepatide right for you, and who should avoid it?
Often considered for
- Adults with obesity, or overweight plus at least one weight-related condition (Zepbound)
- Adults with obesity and moderate to severe obstructive sleep apnea (Zepbound)
- Adults and children 10 and older with type 2 diabetes (Mounjaro)
Not a fit, or needs extra care
- Anyone with a personal or family history of medullary thyroid cancer or MEN 2
- Pregnancy: stop when pregnancy is recognized
- Anyone who has had a serious allergic reaction to tirzepatide
- People with severe GI disease, or a history of pancreatitis or gallbladder disease, need a careful conversation first
- If you use birth control pills, the label advises switching to a non-oral method or adding a barrier method for a period after starting and after each dose increase
Only a licensed clinician who knows your history can decide whether it is right for you.
What are the risks and side effects of Tirzepatide?
- Boxed warning: thyroid C-cell tumors in rodents. Not for people with a personal or family history of medullary thyroid cancer or MEN 2.
- GI side effects (nausea, diarrhea, vomiting, constipation) are common; label warnings include pancreatitis, gallbladder problems and kidney injury from dehydration.
- It can make oral birth control less reliable for a period after starting and after dose changes; the label advises a backup or non-oral method.
- Low blood sugar risk rises when combined with insulin or sulfonylureas. Not for use in pregnancy.
- FDA has received hundreds of adverse event reports tied to compounded tirzepatide.
What should you ask a clinician about Tirzepatide?
- Is Zepbound or Mounjaro the right fit for me, and what will coverage look like?
- Do I need to change my contraception while starting this?
- How will we decide whether it is working and how long I stay on it?
These save with the compound when you add it to My Journal, so they’re on the printout for your visit.
How do people get Tirzepatide through telehealth?
Answer an online health questionnaire about your weight history, conditions and medications.
A licensed clinician reviews it. Depending on your state and the program, that is either an asynchronous review or a short video or phone visit.
Some programs ask for recent labs, or send an at-home kit, before or soon after prescribing.
If prescribed, the medication ships to you or is sent to a local pharmacy. Branded pens covered by insurance usually need a prior authorization first.
Follow-ups happen by message or visit as your clinician adjusts treatment, typically monthly early on.
Labs you may be asked for
- A metabolic panel (kidney and liver function)
- A1C or fasting glucose
- A lipid panel
- Thyroid tests at some programs
- Many programs accept results from the past year instead of new tests
What programs often include
- Clinician review and ongoing prescription management
- Messaging with the care team about side effects and dose changes
- Nutrition coaching or registered dietitian support at some programs
- Insurance and prior-authorization help at programs that take insurance
Check your levels first
Some services let you order common lab tests yourself, so the results are ready for your visit. Your clinician decides which labs, if any, you need, and what the results mean.
- Function HealthAnnual membership for broad lab panels, drawn at Quest sites or at home.Visit
- Quest HealthOrder individual lab tests from Quest Diagnostics online, without a doctor’s visit.Visit
From each service’s own site, checked September 23, 2026.
How some providers do it
- RoBranded Zepbound with cash-pay or insurance; the membership includes an insurance concierge, provider messaging and coaching.
- LifeMDAccepts insurance and Medicare; labs are encouraged but not required before the first prescription.
- EdenSells compounded tirzepatide: a short questionnaire, clinician review within a day, and provider-directed labs when needed. Its page discloses that compounded drugs are not FDA-reviewed.
- MaximusOnline evaluation with no appointment needed and physician review; offers compounded and branded options, but not in every state.
- Amazon PharmacyFills a prescription from your own clinician, with insurance or cash pricing.
From each provider’s own site, checked September 23, 2026. Programs change, so confirm the details before you sign up.
Where can I get Tirzepatide?
22 providers list Tirzepatide on DiscoverMedica, lowest listed price first.
Mochi HealthCompounded tirzepatide weekly injection
Compounded, not FDA-approvedLowest listed priceClinician consult required
From $90listed price†
Start at Mochi Health $129/molisted price†
Start at Eden Starting at $133/mo + program feelisted price†
Start at Ivim Health Starts at $179/monthlisted price†
Start at Henry Meds From $249.99listed price†
Start at Maximus From $299/molisted price†
Start at Hers From $299/molisted price†
Start at Hims $299/mo + $49/mo membershiplisted price†
Start at Lemonaid Health From $299listed price†
Start at LifeMD From $299listed price†
Start at Mochi Health $299/molisted price†
Start at Ro Starting at $349 per monthlisted price†
Start at Rex MD Starting at $499/molisted price†
Start at LillyDirect Noom MedNoom Microdose GLP-1Rx (compounded tirzepatide)
Compounded, not FDA-approvedClinician consult required
Plans start at $791listed price†
Start at Noom Med see site
Start at Amazon Pharmacy see site
Start at Amazon Pharmacy see site
Start at Found see site
Start at Healthspan see site
Start at Lemonaid Health see site
Start at LillyDirect see site
Start at Noom Med see site
Start at Nurx see site
Start at PlushCare † Prices as listed by the provider when we checked; they change.
How much does Tirzepatide cost?
Listed prices run from $129 to $499 a month across 8 providers, as checked October 7, 2026.
Prices as listed by the provider when we checked; they change. Membership or consult fees may be separate; see each provider.
Compare and learn
- Tirzepatide vs semaglutide: how do Zepbound and Mounjaro compare with Wegovy and Ozempic?
- Retatrutide vs tirzepatide: how does the investigational triple agonist compare?
- Compounded tirzepatide and semaglutide: how do they differ from the brands?
- What are peptides, what is peptide therapy, and are peptides legal?
- Peptides for weight loss: which are approved, and which are not?
- How much does Zepbound cost without insurance?
Tirzepatide: questions, answered
What is the difference between Zepbound and Mounjaro?
Both are tirzepatide. Zepbound is approved for weight management and sleep apnea. Mounjaro is approved for type 2 diabetes. Insurance often covers them differently.
How does it compare with semaglutide?
Tirzepatide acts on two hormone receptors instead of one. In separate trials, average weight loss was somewhat higher with tirzepatide, and a head-to-head trial found the same. Side effects are similar. Your clinician can help weigh cost, coverage and your health history.
Does it affect birth control?
It can make birth control pills less reliable for a while after starting and after each dose increase. The label advises a non-oral method or a backup barrier method during those windows.
Is compounded tirzepatide safe?
Compounded versions are not FDA-approved or reviewed, and FDA has received hundreds of adverse event reports about them. Medical societies advise using FDA-approved products.
Can I get it through telehealth?
Yes. Many licensed telehealth providers prescribe branded tirzepatide after an online intake, and some also sell compounded versions.
Important safety information
Key risks
- Boxed warning: thyroid C-cell tumors in rodents. Not for people with a personal or family history of medullary thyroid cancer or MEN 2.
- GI side effects (nausea, diarrhea, vomiting, constipation) are common; label warnings include pancreatitis, gallbladder problems and kidney injury from dehydration.
- It can make oral birth control less reliable for a period after starting and after dose changes; the label advises a backup or non-oral method.
- Low blood sugar risk rises when combined with insulin or sulfonylureas. Not for use in pregnancy.
- FDA has received hundreds of adverse event reports tied to compounded tirzepatide.
Talk to a clinician first, or avoid it, if
- Anyone with a personal or family history of medullary thyroid cancer or MEN 2
- Pregnancy: stop when pregnancy is recognized
- Anyone who has had a serious allergic reaction to tirzepatide
- People with severe GI disease, or a history of pancreatitis or gallbladder disease, need a careful conversation first
- If you use birth control pills, the label advises switching to a non-oral method or adding a barrier method for a period after starting and after each dose increase
This is not a complete list of risks. Read the full prescribing information and any Medication Guide, and talk to a licensed clinician or pharmacist about your own situation. If you have a severe reaction, call 911. You can report side effects to the FDA through MedWatch at 1-800-FDA-1088.
Sources
- DailyMed: Zepbound prescribing information
- SURMOUNT-1: Tirzepatide once weekly for the treatment of obesity (NEJM 2022)
- FDA (Apr 30, 2026): Proposal to exclude semaglutide, tirzepatide and liraglutide from the 503B bulks list
Also checked for this guide
- SURMOUNT-4: Continued tirzepatide vs placebo for maintenance of weight reduction (JAMA 2024)
- SURMOUNT-OSA: Tirzepatide for obstructive sleep apnea and obesity (NEJM 2024)
- FDA (Dec 2024): FDA approves first medication for obstructive sleep apnea
- ADA Standards of Care 2026, Section 8: Obesity and weight management (Guideline Central summary)
- AACE consensus statement: algorithm for the evaluation and treatment of adults with obesity (2025)
- Obesity Medicine Association, The Obesity Society and Obesity Action Coalition: statement on compounded GLP-1s (Jan 2024)
- FDA: Concerns with unapproved GLP-1 drugs used for weight loss
- Tirzepatide vs semaglutide for obesity: SURMOUNT-5 (NEJM 2025)
- Ro: Weight loss, how it works
- LifeMD: Weight management
- Eden: GLP-1 weight loss
- Maximus: Weight loss
- Amazon Pharmacy
Guide reviewed September 23, 2026.
Educational information only, not medical advice. It does not replace a conversation with a licensed clinician.
Example journals
Journals with Tirzepatide.
Same goal
Related compounds.
Semaglutide
medicationA GLP-1 medication that reduces appetite, approved for weight management and type 2 diabetes.
24 providers
Liraglutide
medicationAn older, daily GLP-1 injection for weight management and diabetes, now available as a generic.
12 providers
Retatrutide
peptideAn investigational triple-hormone weight-loss drug from Eli Lilly. Not approved; only available in trials.
Education only
Metformin
medicationA cheap, decades-old diabetes pill that some people ask about for weight and healthy aging.
12 providers